Healthcare Industry News:  ultrasound imaging 

Devices Oncology

 News Release - August 27, 2009

Resonant Medical to Exhibit Next Generation Clarity System at Europe's Pre-Eminent Radiation Oncology Conference

MAASTRO Clinic introduces Clarity System, available throughout Europe for guidance, planning and adaptive radiotherapy in soft tissue cancers, for first time in the Netherlands

MONTREAL--(HSMN NewsFeed)--Resonant Medical, an innovator in soft tissue planning, image-guidance and adaptive radiotherapy products, today announced that the Company will be exhibiting the next generation of its multi-anatomy Clarity System at the 10th Biennial Meeting of The European Society of Therapeutic Radiology and Oncologists (ESTRO), being held in Maastricht, Netherlands.

Clarity provides cost effective soft tissue hybrid imaging, integrated within a singular point-of-care in the CT Suite. Clarity also provides structure based image-guided radiotherapy (IGRT) during daily radiation treatments. The next generation version of Clarity also supports adaptive radiotherapy by alerting physicians of changes in a target structure’s precise location, shape and size and enabling them to use this information to adapt the patient’s treatment plan as necessary. Additionally, the MAASTRO Clinic in Maastricht has begun offering the Clarity System for its prostate and breast treatments.

“We are honoured that the prestigious MAASTRO Clinic has adopted the Clarity System for clinical use in advanced planning and soft tissue based IGRT, thus expanding the availability of better patient care in Europe,” said Tony Falco, founder and CEO of Resonant Medical. “Our continued momentum in the European market is further evidence that the radiation oncology community is recognizing the need to address the issue of tumor movement in soft tissue cancers, like breast cancer. As we unveil the latest generation of Clarity products at ESTRO, we hope to make the Clarity System available to an increasing number of cancer patients in Europe.”

During the radiation treatment planning phase, Clarity allows physicians to automatically compare CT and 3D ultrasound images acquired at the same time with the patient in the same position, which can dramatically improve the treatment planning workflow when compared to CT alone. The Clarity System is based on daily auto-contouring and true 3D anatomy changes during the entire course of treatment, ensuring rapid and precise daily delivery to the intended target while sparing healthy tissue. Clarity’s 3D ultrasound imaging is a gentle, non-invasive technology most often associated with pregnancy and providing images of babies. In addition to adding the Clarity System to treatment for breast and prostate cancer patients, physicians at MAASTRO will be exploring how the system may improve treatment planning and targeting in GYN, bladder and liver cancer patients.

“The MAASTRO Clinic is excited to offer this new application of 3D ultrasound technology that advances patient care by providing more accurate planning and guidance in the delivery of treatment to patients battling breast and prostate cancer,” said Dr. Frank Verhaegen, Head of Physics at MAASTRO. “The Clarity System is radiation-free and with the information it provides physicians, patients can rest easier knowing that their radiation treatment can be delivered directly to the area where it is needed most. We are also excited about possible future collaborations with Resonant to develop additional applications of the Clarity System to continue addressing the issue of tumor movement in soft tissue cancers.”

About the MAASTRO Clinic

MAASTRO Clinic (Maastricht Radiation Oncology Clinic; is a dedicated radiotherapy clinic, which has strategic agreements with the GROW research institute (School for Developmental Biology and Oncology;, the Faculty of Health, Medicine and Life Sciences at Maastricht University and the University Hospital of Maastricht. MAASTRO Clinic offers state-of-the-art radiotherapy to more than 3500 cancer patients each year from the Limburg area in the Netherlands. One of the missions of MAASTRO Clinic is implementing and developing advanced imaging techniques for image-guided radiotherapy.

For further information visit:

About Resonant Medical

Resonant Medical (Montreal, Canada) develops, manufactures and commercializes 3D ultrasound planning, image-guidance, and adaptive radiotherapy products. Resonant’s technologies are available in cancer centers throughout the U.S., Canada and Europe, helping cancer centers make significant improvements in patient care.

For further information visit:

Source: Resonant Medical

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.